5 Best Biotech Bets Likely To Outperform Estimates In Q4

bluebird bio, Inc. (BLUE - Free Report) has an Earnings ESP of +5.87% and is a #3 Ranked stock. The consensus mark for the fourth quarter stands at a loss of $2.78. The company will announce results on Feb 20.

1 2 3
View single page >> |

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.